Browse
Prediction results retrieved after performance evaluation of WHO approved 34 primers to estimate their binding affinities for 3892 SARS-CoV-2 variants.

Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used
  
BA.5.2.46EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.2.46EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.2.46ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.2.46ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
BA.5.7EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
BA.5.7EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
BA.5.7ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
BA.5.7ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
BA.5.7EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
BA.5.7EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
BA.5.7ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
BA.5.7ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CU.1EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-18253.7South Korea
CU.1EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CU.1ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-22616.4Germany
CU.1ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CU.1EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CU.1EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CU.1ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CU.1ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
CA.2EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-15016.3South Korea
CA.2EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
CA.2ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-19379.1Germany
CA.2ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
CA.2EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
CA.2EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
CA.2ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
CA.2ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.83EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.83EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.83ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.83ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.83EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.83EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.83ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.83ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.177.75EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.177.75EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.177.75ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.177.75ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.177.75EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.177.75EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
B.1.177.75ENiu-ETTCTTGCTTTCGTGGTATTC20402630326322F-19913.4China
B.1.177.75ENiu-ECACGTTAACAATATTGCAGC20402639126372R-20723.8China
B.1.411EWon-ETTCGGAAGAGACAGGTACGTT2147.622625926279F-22650South Korea
B.1.411EWon-ECACACAATCGATGCGCAGTA20502636526346R-19261.4South Korea
B.1.411ECharité-EACAGGTACGTTAATAGTTAATAGCGT2634.622626926294F-24645.6Germany
B.1.411ECharité-EATATTGCAGCAGTACGCACACA2245.452638126360R-23527.6Germany
B.1.411EHuang-EACTTCTTTTTCTTGCTTTCGTGGT2437.52629526318F-25022.8China
B.1.411EHuang-EGCAGCAGTACGCACACAATC20552637626357R-23540.5China
Lineage
(WHO label)
  
Target Gene
  
Primer Name
  
Primer Sequence
  
Primer Length
  
Primer GC Content (%)
  
Start Position
  
End Position
  
Primer Direction
  
ΔG (cal)
  
Primer first used